Actively Recruiting
Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders Using a Multidimensional Assessment Battery
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-16
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
A
Assistance Publique - Hôpitaux de Paris
Lead Sponsor
U
URC-CIC Paris Descartes Necker Cochin
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying social cognition profiles in children and adolescents aged 8 to 16 with neurodevelopmental disorders, including Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder, and multiple complex developmental disorder. The study aims to better understand social cognition, which plays a key role in development and social integration, but is often under-assessed in these patients due to a lack of validated tools. Participants will complete a multidimensional social cognition battery developed by the Child and Adolescent Psychiatry Department of Necker-Enfants Malades Hospital. This battery evaluates four key social cognition areas emotion processing, social perception, theory of mind, and attributional style. Additional tasks assessing social cognition and executive function, as well as parent questionnaires, will also be administered. Children and adolescents will be recruited during diagnostic or follow-up visits at the hospital. Assessments include the social cognition battery, supplementary tests, and questionnaires for parents. Researchers will measure overall social cognition scores and scores by dimension, along with the influence of socio-demographic and cognitive factors. The study runs until April 2029 and involves no masking or randomization.
CONDITIONS
Brief Title
Characterization of Social Cognition Profiles in Children and Adolescents With Neurodevelopmental Disorders: a Clinical Study Using a Multidimensional Battery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children and adolescents aged 8 to 16 years
- Proficient in French as their native language
- Consent obtained from parent or guardian and agreement from the child or adolescent
- No recent changes (within 6 weeks) in psychotropic medications including antidepressants, anxiolytics, antipsychotics, psychostimulants, or mood stabilizers
- IQ above 70 measured by WISC-V
- Diagnosis of Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder according to DSM-5
- Symptoms of a neurodevelopmental disorder with multiple complex developmental disorder criteria met with at least 5 specified elements
You will not qualify if you...
- Having an active neurological disorder such as active epilepsy
Research Team
D
Dorothée Leunen
H
Hélène Morel
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here